Mechanism of nicotine-evoked release of [ 3H]-noradrenaline in human cerebral cortex slices

British Journal of Pharmacology

Volumn 137, Issue 7, 2002, Pages 1063-1070

  Woo, Ran Sook ^a   Park, Eun Young ^a   Shin, Min Soo ^a   Jeong, Min Suk ^a   Zhao, Rong Jie ^a   Shin, Byuong Soo ^a   Kim, Chul Jin ^a   Park, Jin Woo ^a   Kim, Kee Won ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Human cerebral cortex; Nicotine; Noradrenaline release

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 AMINO 5 PHOSPHONOVALERIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 7 NITROINDAZOLE; ALPHA BUNGAROTOXIN; CALCIUM ION; CHOLINERGIC RECEPTOR; CYCLIC GMP; DEXTRO ASPARTIC ACID; DIHYDRO BETA ERYTHROIDINE; DIZOCILPINE; MECAMYLAMINE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NICOTINE; NISOXETINE; NITRENDIPINE; NITRIC OXIDE; NORADRENALIN; OMEGA CONOTOXIN; TETRODOTOXIN; TRITIUM; TUBOCURARINE CHLORIDE; ZAPRINAST; 1H (1,2,4)OXADIAZOLO(4,3 A)QUINOXALIN 1 ONE; 1H-(1,2,4)OXADIAZOLO(4,3-A)QUINOXALIN-1-ONE; 7-NITROINDAZOLE; ARGININE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIZOCILPINE MALEATE; DRUG DERIVATIVE; ENZYME INHIBITOR; FLUOXETINE; GANGLION STIMULATING AGENT; GUANYLATE CYCLASE; INDAZOLE DERIVATIVE; METHYLENE BLUE; N(G) MONOMETHYLARGININE ACETATE; N(G)-MONOMETHYLARGININE ACETATE; NEUROPROTECTIVE AGENT; NICOTINIC RECEPTOR BLOCKING AGENT; NITRIC OXIDE SYNTHASE; OMEGA CONOTOXIN GVIA; OXADIAZOLE DERIVATIVE; PURINE DERIVATIVE; QUINOXALINE DERIVATIVE;

ADRENALIN RELEASE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING; DRUG MECHANISM; DRUG SENSITIVITY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ADOLESCENT; ADULT; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; MALE; METABOLISM; SECRETION;

ADOLESCENT; ADULT; ARGININE; CALCIUM; CALCIUM CHANNEL BLOCKERS; CEREBRAL CORTEX; DIHYDRO-BETA-ERYTHROIDINE; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLUOXETINE; GANGLIONIC STIMULANTS; GUANYLATE CYCLASE; HUMANS; INDAZOLES; MALE; MECAMYLAMINE; METHYLENE BLUE; NEUROPROTECTIVE AGENTS; NG-NITROARGININE METHYL ESTER; NICOTINE; NICOTINIC ANTAGONISTS; NITRENDIPINE; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; OMEGA-CONOTOXIN GVIA; OXADIAZOLES; PURINONES; QUINOXALINES; TETRODOTOXIN; TRITIUM; TUBOCURARINE;

EID: 0036897798     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704975     Document Type: Article

References (79)

1. Ague, C. (1973). Nicotine and smoking: Effects upon subjective changes in mood. Psychopharmacologia, 30, 323-328.
2. 3H]-norepinephrine from rat brain slices using a new 96-well format assay. Neuropharmacology, 39, 2663-2672.
3. Anlezark, G.M., Crow, T.J. & Greenway, A.P. (1973). Impaired learning and decreased cortical norepinephrine after bilateral locus coeruleus lesions. Science, 181, 682-684.
4. Aston-Jones, G. & Bloom, F.E. (1981). Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J. Neurosci., 1, 876-886.
5. Baron, J.A. (1996). Beneficial effects of nicotine and cigarette smoking: The real, the possible and the spurious. Br. Med. Bull., 52, 58-73.
6. Callado, L.F., Hopwood, S.E., Hancock, P.J. & Stamford, J.A. (2000). Effects of dizocilpine (MK 801) on noradrenaline, serotonin and dopamine release and uptake. Neuroreport, 11, 173-176.
7. Carli, M., Robbins, T.W., Evenden, J.L. & Everitt, B.J. (1983). Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav. Brain Res., 9, 361-380.
8. Castellano, C. (1976). Effects of nicotine on discrimination learning, consolidation and learned behaviour in two inbred strains of mice. Psychopharmacology (Berl), 48, 37-43.
9. 125I]-alpha-bungarotoxin. J. Neurosci., 5, 1307-1315.
10. 3H]-dopamine release. Br. J. Pharmacol., 117, 595-606.
11. Decker, M.W., Brioni, J.D, Bannon, A.W. & Arneric, S.P. (1995). Diversity of neuronal nicotinic acetylcholine receptors: Lessons from behavior and implications for CNS therapeutics. Life Sci., 56, 545-570.
12. Devauges, V. & Sara, S.J. (1990). Activation of the noradrenergic system facilitates an attentional shift in the rat. Behav. Brain Res., 39, 19-28.
13. Diamond, I., Gordon, A.S., Davis, C.G. & Milfay, D. (1983). Phenytoin and phosphorylation of nicotinic receptors. Adv. Neurol., 34, 339-344.
14. Domino, E.F. & Yamamoto, K.I. (1965). Nicotine: Effect on the sleep cycle of the cat. Science, 150, 637-638.
15. Egberongbe, Y.I., Gentleman, S.M., Falkai, P., Bogerts, B., Polak, J.M. & Roberts, G.W. (1994). The distribution of nitric oxide synthase immunoreactivity in the human brain. Neuroscience, 59, 561 - 578.
16. Elgoyhen, A.B., Vetter, D.E., Katz, E., Rothlin, C.V., Heinemann, S.F. & Boulter, J. (2001). Alpha 10: A determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc. Natl. Acad. Sci. U.S.A., 98, 3501-3506.
17. Fedele, E., Varnier, G., Ansaldo, M.A. & Raiteri, M. (1998). Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release. Br. J. Pharmacol., 125, 1042-1048.
18. Fernandez, J.M., Granja, R., Izaguirre, V., Gonzalez-Garcia, C. & CENA, V. (1995). omega-Conotoxin GVIA blocks nicotine-induced catecholamine secretion by blocking the nicotinic receptor-activated inward currents in bovine chromaffin cells. Neurosci. Lett., 191, 59-62.
19. Fink, K., Schultheiss, R. & Gothert, M. (1992). Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors. Br. J. Pharmacol., 106, 67-72.
20. 3H]-nicotine binding in human cerebral cortex: Comparison between Alzheimer's disease and the normal. J. Neurochem., 47, 1948-1954.
21. Fontana, G., Fedele, E., Cossu, M., Munari, C. & Raiteri, M. (1997). Activation of brain nitric oxide synthase in depolarized human temporal cortex slices: Differential role of voltage-sensitive calcium channels. Br. J. Pharmacol., 122, 930-934.
22. 3H]norepinephrine from fetal rat locus coeruleus cells in culture. J. Neurochem., 70, 663-670.
23. Garthwaite, J. (1995). Neural nitric oxide signalling. Trends Neurosci., 18, 51 - 52.
24. 3H]dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem., 59, 848-856.
25. Harsing JR., L.G., Sershen, H., Vizi, S.E. & Lajtha, A. (1992). N-type calcium channels are involved in the dopamine releasing effect of nicotine. Neurochem. Res., 17, 729-734.
26. Hennings, EC., Kiss, J.P., De Oliveira, K., Toth, P.T. & Vizi, E.S. (1999). Nicotinic acetylcholine receptor antagonistic activity of monoamine uptake blockers in rat hippocampal slices. J. Neurochem., 73, 1043-1050.
27. Kamiya, Y., Andoh, T., Watanabe, I., Higashi, T. & Itoh, H. (2001). Inhibitory effects of barbiturates on nicotinic acetylcholine receptors in rat central nervous system neurons. Anesthesiology, 94, 694-704.
28. Karlin, A. (1993). Structure of nicotinic acetylcholine receptors. Curr. Opin. Neurobiol., 3, 299-309.
29. Kiss, J.P., Sershen, H., Lajtha, A. & Vizi, E.S. (1996). Inhibition of neuronal nitric oxide synthase potentiates the dimethylphenylpiperazinium-evoked carrier-mediated release of noradrenaline from rat hippocampal slices. Neurosci. Lett., 215, 115-118.
30. 3H]GABA) release from rat hippocampal slices by nicotinic receptor activation. J. Pharmacol. Exp. Ther., 295, 453-462.
31. 3H]-noradrenaline release in rabbit brain cortex. Naunyn Schmiedebergs Arch. Pharmacol., 353, 46-54.
32. 2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors. J. Neurosci., 17, 9035-9047.
33. Leonard, S., Adams, C., Breese, CR., Adler, L.E., Bickford, P., Byerley, W., Coon, H., Griffith, J.M., Miller, C., Myles-Worsley, M., Nagamoto, H.T., Rollins, Y., Stevens, K.E., Waldo, M. & Freedman, R. (1996). Nicotinic receptor function in schizophrenia. Schizophr. Bull., 22, 431-455.
34. Lerner-Marmarosh, N., Carroll, F.I. & Abood, L.G. (1995). Antagonism of nicotine's action by cocaine analogs. Life Sci., 56, PL67-70.
35. Levin, E.D., Briggs, S.J., Christopher, N.C. & Rose, J.E. (1992). Persistence of chronic nicotine-induced cognitive facilitation. Behav. Neural. Biol., 58, 152-158.
36. + channel activation in porcine adrenal chromaffin cells. J. Pharmacol. Exp. Ther., 277, 1209-1214.
37. Liang, S.D. & Vizi, E.S. (1997). Positive feedback modulation of acetylcholine release from isolated rat superior cervical ganglion. J. Pharmacol. Exp. Ther., 280, 650-655.
38. Lindstrom, J. (1997). Nicotinic acetylcholine receptors in health and disease. Mol. Neurobiol., 15, 193-222.
39. 3H]norepinephrine release. II. The role of calcium, reverse norepinephrine transport and cyclic 3′,5′-guanosine monophosphate. J. Pharmacol. Exp. Ther., 275, 14-22.
40. + efflux from mouse brain synaptosomes. J. Pharmacol. Exp. Ther., 274, 833-841.
41. Marshall, D.L., Redfern, P.H. & Wonnacott, S. (1997). Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: Comparison of naive and chronic nicotine-treated rats. J. Neurochem., 68, 1511-1519.
42. Marshall, D., Soliakov, L., Redfern, P. & Wonnacott, S. (1996). Tetrodotoxin-sensitivity of nicotine-evoked dopamine release from rat striatum. Neuropharmacology, 35, 1531-1536.
43. McGehee, D.S., Heath, M.J., Gelber, S., Devay, P. & Role, L.W. (1995). Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science, 269, 1692-1696.
44. Moncada, S., Palmer, R.M. & Higgs, E.A. (1991). Nitric oxide: Physiology, pathophysiology, and pharmacology, Pharmacol. Rev., 43, 109-142.
45. Montague, P.R., Gancayco, CD., Wlnn, M.J., Marchase, R.B. & Friedlander, M.J. (1994). Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science, 263, 973-977.
46. Mulle, C., Choquet, D., Korn, H. & Changeux, J.P. (1992). Calcium influx through nicotinic receptor in rat central neurons: Its relevance to cellular regulation. Neuron, 8, 135-143.
47. Munson, P.J. & Rodbard, D. (1980). Ligand: A versatile computerized approach for characterization of ligand-binding system. Anal. Biochem., 107, 220-239.
48. 3H]D-aspartate outflow from various in vitro preparations of the rat hippocampus. Neurochem. Int., 31, 113-124.
49. 3H]nicotine binding sites in rat brain regions: An autoradiographic study. Brain Res. Dev. Brain Res., 68, 163-174.
50. Nordberg, A., Alafuzoff, I. & Winblad, B. (1992). Nicotinic and muscarinic subtypes in the human brain: Changes with aging and dementia. J. Neurosci. Res., 31, 103-111.
51. Olivera, B.M., McIntosh, J.M., Cruz, L.J., Luque, F.A. & Gray, W.R. (1984). Purification and sequence of a presynaptic peptide toxin from Conus geographus venom. Biochemistry, 23, 5087-5090.
52. Paterson, D. & Nordberg. A. (2000). Neuronal nicotinic receptors in the human brain. Prog. Neurobiol., 61, 75-111.
53. Perez De La Mora, M., Mendez-Franco, J., Salceda, R., Aguirre, J.A. & Fuxe, K. (1991). Neurochemical effects of nicotine on glutamate and GABA mechanisms in the rat brain. Acta Physiol. Scand., 141, 241-250.
54. Pittaluga, A., Pattarini, R., Andrioli, G.C., Viola, C., Munari, C. & Raiteri, M. (1999). Activity of putative cognition enhancers in kynurenate test performed with human neocortex slices. J. Pharmacol. Exp. Ther., 290, 423-428.
55. Pogun, S., Demirgoren, S., Taskiran, D., Kanit, L., Yilmaz, O., Koylu, E.O., Balkan, B. & London, E.D. (2000). Nicotine modulates nitric oxide in rat brain. Eur. Neuropsychopharmacol., 10, 463-472.
56. Pomerleau, O.F. (1992). Nicotine and the central nervous system: Biobehavioral effects of cigarette smoking. Am. J. Med., 93, 2S-7S.
57. Prast, H. & Philippu, A. (2001). Nitric oxide as modulator of neuronal function. Prog. Neurobiol., 64, 51-68.
58. Raiteri, M., Bonanno, G., Maura, G., Pende, M., Andrioli, G.C. & Ruelle, A. (1992a). Subclassification of release-regulating alpha 2-autoreceptors in human brain cortex. Br. J. Pharmacol., 107, 1146-1151.
59. Raiteri, M., Garrone, B. & Pittaluga, A. (1992b). N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal. J. Pharmacol. Exp. Ther., 260, 238-242.
60. Ramoa, A.S., Alkondon, M., Aracava, Y., Irons, J., Lunt, G.G., Deshpande, S.S., Wonnacott, S., Aronstam, R.S. & Albuquerque, E.X. (1990). The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. J. Pharmacol. Exp. Ther., 254, 71-82.
61. Rana, B., McMorn, S.O., Reeve, H.L., Wyatt, C.N., Vaughan, P.F. & Peers, C. (1993). Inhibition of neuronal nicotinic acetylcholine receptors by imipramine and desipramine. Eur. J. Pharmacol., 250, 247-251.
62. Redmond JR., D.E. & Huang, Y.H. (1979). Current concepts. II. New evidence for a locus coeruleus-norepinephrine connection with anxiety. Life Sci., 25, 2149-2162.
63. 3H]desmethylimipramine binding in bovine adrenal medulla: Interactions with sigma- and (or) phencyclidine-receptor ligands. Can. J. Physiol. Pharmacol., 70, 1508-1514.
64. Rubboli, F., Court, J.A., Sala, C., Morris, C., Perry, E. & Clementi, F. (1994). Distribution of neuronal nicotinic receptor subunits in human brain. Neurochem. Int., 25, 69-71.
65. Sacaan, A.I., Dunlop, J.L. & Lloyd, G.K. (1995). Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J. Pharmacol. Exp. Ther., 274, 224-230.
66. Sanchez-Merino, J.A., Marin, J., Balfagon, G. & Ferrer, M. (1995). Involvement of alpha 2-adrenoceptors and protein kinase C on nicotine-induced facilitation or noradrenaline release in bovine cerebral arteries. Gen. Pharmacol., 26, 827-833.
67. Smith, D.A., Hoffman, A.F., David, D.J., Adams, C.E. & Gerhardt, G.A. (1998). Nicotine-evoked nitric oxide release in the rat hippocampal slice. Neurosci. Lett., 255, 127-130.
68. Steinlein, O.K., Mulley, J.C., Propping, P., Wallace, R.H., Phillips, H.A., Sutherland, G.R., Scheffer, I.E. & Berkovic, S.F. (1995). A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet., 11, 201-203.
69. Sunderland, T., Tariot, P.N. & Newhouse, P.A. (1988). Differential responsivitiy of mood, behavior, and cognition to cholinergic agents in elderly neuropsychiatric populations. Brain Res., 472, 371-389.
70. Toth, E., Sershen, H., Hashim, A, Vizi, E.S. & Lajtha, A. (1992). Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: Role of glutamic acid. Neurochem. Res., 17, 265-271.
71. 2+ channel block by highly hydrophilic dihydropyridines in single ventricular cells of guinea-pig hearts. J. Mol. Cell. Cardiol., 27, 1271-1279.
72. Werling, L.L., Brown, S.R. & Cox, B.M. (1987). Opioid receptor regulation of the release of norepinephrine in brain. Neuropharmacology, 26, 987-996.
73. Wessler, I. (1992). Acetylcholine at motor nerves: Storage, release, and presynaptic modulation by autoreceptors and adrenoceptors. Int. Rev. Neurobiol., 34, 283-384.
74. 3H-norepinephrine and 3H-dopamine from rat brain slices. Neuropharmacology, 13, 693-700.
75. Wonnacott, S. (1997). Presynaptic nicotinic ACh receptors. Trends Neurosci., 20, 92-98.
76. Wonnacott, S., Kaiser, S., Mogg, A., Soliakov, L. & Jones, I.W. (2000). Presynaptic nicotinic receptors modulating dopamine release in the rat striatum Eur. J. Pharmacol., 393, 51-58.
77. Yilmaz, O., Kanit, L., Okur, B.E., London, E.D. & Pogun, S. (2000). Nitric oxide synthetase inhibition hinders facilitation of active avoidance learning by nicotine in rats. Behav. Pharmacol., 11, 505-510.
78. Yoshimura, R., Yanagihara, N., Terao, T., Minami, K., Abe, K. & Izumi, F. (1995). Inhibition by carbamazepine of various ion channels-mediated catecholamine secretion in cultured bovine adrenal medullary cells. Naunyn Schmiedebergs Arch. Pharmacol., 352, 297-303.
79. Zornetzer, S.F., Abraham, W.C. & Appleton, R. (1978). Locus coeruleus and labile memory. Pharmacol. Biochem. Behav., 9, 227-234.